Vincerx Pharma Inc reports results for the quarter ended in September - Earnings Summary

Vincerx Pharma

10/11/2022 23:39

* Vincerx Pharma Inc  VINC.OQ  reported a quarterly adjusted
loss
of 80 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 55 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vincerx Pharma Inc's reported EPS for the quarter was a
loss
of 80 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Vincerx Pharma Inc shares had fallen by 33.0% this
quarter and
lost 90.9% so far this year.
    * The company reported a quarterly loss of $16.88 million.
    * Wall Street's median 12-month price target for Vincerx
Pharma
Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:39 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.55          -0.80          Missed
 Jun. 30 2022      -0.79          -0.88          Missed
 Mar. 31 2022      -0.76          -0.79          Missed
 Dec. 31 2021      -0.93          -0.31          Beat